Targeting galectin-driven regulatory circuits in cancer and fibrosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 22, Issue 4, Pages 295-316
Publisher
Springer Science and Business Media LLC
Online
2023-02-09
DOI
10.1038/s41573-023-00636-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
- (2022) Julia Femel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens
- (2022) Anna V. Blenda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression
- (2022) Pablo Carabias et al. Cell Death & Disease
- A roadmap for translational cancer glycoimmunology at single cell resolution
- (2022) Andreia Peixoto et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
- (2022) Raquel Roldán-Montero et al. Science Advances
- Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3
- (2022) Chunjian Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin‐1–RNA interaction map reveals potential regulatory roles in angiogenesis
- (2021) Jiajun Wei et al. FEBS LETTERS
- Intracellular immune sensing promotes inflammation via gasdermin D–driven release of a lectin alarmin
- (2021) Ashley J. Russo et al. NATURE IMMUNOLOGY
- The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
- (2021) Benjamin A. H. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- Reprogramming the tumor metastasis cascade by targeting galectin-driven networks
- (2021) Ramiro M. Perrotta et al. BIOCHEMICAL JOURNAL
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
- (2021) Marina Stasenko et al. Scientific Reports
- SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells
- (2021) Conor J. Kearney et al. Science Advances
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression
- (2021) Seok-Jun Kim et al. Gastric Cancer
- The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake
- (2021) Álvaro de Mingo Pulido et al. IMMUNITY
- Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors
- (2021) Li Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells
- (2021) Alejandro J. Cagnoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
- (2021) Brendan D Curti et al. Journal for ImmunoTherapy of Cancer
- New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
- (2021) Laetitia Gheysen et al. Cells
- Emerging role of galectin family in inflammatory autoimmune diseases
- (2021) Wang-Dong Xu et al. AUTOIMMUNITY REVIEWS
- A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma
- (2021) Laura Liebscher et al. CANCER LETTERS
- Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3
- (2021) Viktoria Heine et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia
- (2021) Nannan Pang et al. FASEB JOURNAL
- Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits
- (2021) Luciano G. Morosi et al. Science Advances
- Combinatorial Inhibition of Galectin-9 and CHK1 Represent a Novel Treatment Strategy for T-Cell Acute Lymphoblastic Leukemia
- (2021) Miyoung Lee et al. BLOOD
- Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study
- (2021) Daniel Keizman et al. Nutrients
- Full-Length Galectin-3 Is Required for High Affinity Microbial Interactions and Antimicrobial Activity
- (2021) Shang-Chuen Wu et al. Frontiers in Microbiology
- Chemogenetic Control of Nanobodies
- (2020) Helen Farrants et al. NATURE METHODS
- Regioselective 3‐O‐Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors
- (2020) Pavla Bojarová et al. CHEMISTRY-A EUROPEAN JOURNAL
- Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits
- (2020) Verónica C. Martínez Allo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of Galectins in Resistance to Anticancer Therapies
- (2020) Pilar Navarro et al. CLINICAL CANCER RESEARCH
- Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
- (2020) Chuan-xia Zhang et al. Oncogenesis
- Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities
- (2020) Juan M. Pérez Sáez et al. ANGIOGENESIS
- Targeting the CRD F‐face of Human Galectin‐3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative
- (2020) Michelle C. Miller et al. ChemMedChem
- Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
- (2020) Nikhil Hirani et al. EUROPEAN RESPIRATORY JOURNAL
- The therapeutic potential of galectin-3 inhibition in fibrotic disease
- (2020) R.J. Slack et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
- (2020) Satyen H. Gohil et al. Nature Reviews Clinical Oncology
- Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors
- (2020) Isobel Okoye et al. Journal for ImmunoTherapy of Cancer
- Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
- (2020) Carolina Tiraboschi et al. Journal for ImmunoTherapy of Cancer
- Glycosylation in health and disease
- (2019) Colin Reily et al. Nature Reviews Nephrology
- An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
- (2019) Lynda Vuong et al. CANCER RESEARCH
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
- (2019) Stefan Mereiter et al. CANCER CELL
- Selective effects of ginseng pectins on galectin-3-mediated T cell activation and apoptosis
- (2019) Huiting Xue et al. CARBOHYDRATE POLYMERS
- A Galactoside-Binding Protein Tricked into Binding Unnatural Pyranose Derivatives: 3-Deoxy-3-Methyl-Gulosides Selectively Inhibit Galectin-1
- (2019) Kumar Bhaskar Pal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The therapy of idiopathic pulmonary fibrosis: what is next?
- (2019) Vivien Somogyi et al. European Respiratory Review
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
- (2019) Zoe Leung et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
- (2019) María Romina Girotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vivo Veritas: 18F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 Inhibitors
- (2019) Klas Bratteby et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epimers Switch Galectin-9 Domain Selectivity: 3N-Aryl Galactosides Bind the C-Terminal and Gulosides Bind the N-Terminal
- (2019) Mukul Mahanti et al. ACS Medicinal Chemistry Letters
- A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
- (2019) Yao-Tsung Tsai et al. Molecular Therapy-Nucleic Acids
- The Structural Biology of Galectin-Ligand Recognition: Current Advances in Modeling Tools, Protein Engineering, and Inhibitor Design
- (2019) Carlos P. Modenutti et al. Frontiers in Chemistry
- Different angioregulatory activity of monovalent galectin-9 isoforms
- (2018) Ed Aanhane et al. ANGIOGENESIS
- Thiodigalactoside–Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors
- (2018) Hao Zhang et al. BIOCONJUGATE CHEMISTRY
- Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
- (2018) María T. Elola et al. CELLULAR IMMUNOLOGY
- Lactulose as a novel template for anticancer drug development targeting galectins
- (2018) Chandan Kishor et al. Chemical Biology & Drug Design
- Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond Interactions
- (2018) Fredrik R. Zetterberg et al. ChemMedChem
- Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
- (2018) Tsung-Chieh Shih et al. CLINICAL CANCER RESEARCH
- Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes
- (2018) Noor Al-Obaidi et al. FASEB JOURNAL
- Galectins at a glance
- (2018) Ludger Johannes et al. JOURNAL OF CELL SCIENCE
- Correlation between serum galectin-9 levels and liver fibrosis
- (2018) Koji Fujita et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
- (2018) Carlos A. Orozco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation
- (2018) Marta A. Toscano et al. TRENDS IN MOLECULAR MEDICINE
- Chemoenzymatic Synthesis of Galectin Binding Glycopolymers
- (2018) Jessica H. Ennist et al. BIOCONJUGATE CHEMISTRY
- The role of galectin-3 in heart failure and cardiovascular disease
- (2018) Xiao Zhong et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin–glycan specificities in a natural context
- (2018) Mathias Ingemann Nielsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
- (2017) Nathan Koonce et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells
- (2017) Florent Colomb et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
- (2017) Ana L. Mora et al. NATURE REVIEWS DRUG DISCOVERY
- Translating the ‘Sugar Code’ into Immune and Vascular Signaling Programs
- (2017) Juan P. Cerliani et al. TRENDS IN BIOCHEMICAL SCIENCES
- The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer
- (2017) Annika Stiasny et al. Oncology Letters
- Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
- (2017) Monica Gordon-Alonso et al. Nature Communications
- Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers
- (2017) Laetitia Seguin et al. Cancer Discovery
- Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells
- (2017) Ming-Heng Wu et al. Scientific Reports
- Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
- (2016) S. A. Harrison et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Galectins and Immune Responses—Just How Do They Do Those Things They Do?
- (2016) Sandra Thiemann et al. Annual Review of Immunology
- Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
- (2016) Peter P. Ruvolo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Galectin-3 interacts with components of the nuclear ribonucleoprotein complex
- (2016) Katharina Fritsch et al. BMC CANCER
- Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis
- (2016) Kosei Nakajima et al. CANCER RESEARCH
- Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
- (2016) Tamara Delaine et al. CHEMBIOCHEM
- Galectin-1 inhibitors and their potential therapeutic applications: a patent review
- (2016) Helen Blanchard et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update
- (2016) Vanessa Leiria Campo et al. GLYCOCONJUGATE JOURNAL
- A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies
- (2016) Judy R. van Beijnum et al. INTERNATIONAL JOURNAL OF CANCER
- Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer
- (2016) Tao Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
- (2016) John Stegmayr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Selective Galactose–Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
- (2016) Vishal K. Rajput et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo
- (2016) P Storti et al. LEUKEMIA
- RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways
- (2016) L Zhang et al. ONCOGENE
- Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways
- (2016) KE MA et al. ONCOLOGY REPORTS
- Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet
- (2016) Pablo F. Hockl et al. PHARMACOLOGICAL RESEARCH
- Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1
- (2016) Xiao Na Ge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
- (2016) P-F Zhang et al. Cell Death & Disease
- An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells
- (2016) Po-Chun Tseng et al. Oncotarget
- Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway
- (2016) Yang Chong et al. Oncotarget
- Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells
- (2016) Amelia J. Tesone et al. Cell Reports
- Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer
- (2016) Justine Dewald et al. Cells
- Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
- (2016) Alejandro J. Cagnoni et al. Frontiers in Oncology
- Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
- (2016) Tung-Ju Hsieh et al. Scientific Reports
- Galectin expression in cancer diagnosis and prognosis: A systematic review
- (2015) Victor L. Thijssen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
- (2015) Melanie R. Rutkowski et al. CANCER CELL
- The effect of the size of fluorescent dextran on its endocytic pathway
- (2015) Lei Li et al. CELL BIOLOGY INTERNATIONAL
- Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation
- (2015) Tilman Läppchen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain
- (2015) Michelle C Miller et al. GLYCOBIOLOGY
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy
- (2015) Yugo Mori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The galectin lattice at a glance
- (2015) I. R. Nabi et al. JOURNAL OF CELL SCIENCE
- Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
- (2015) María L. Bacigalupo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
- (2015) Carmel B. Nanthakumar et al. NATURE REVIEWS DRUG DISCOVERY
- Pectin in cancer therapy: A review
- (2015) Wenbo Zhang et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
- (2015) Atsuhiro Kanda et al. Scientific Reports
- Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation
- (2015) Miguel Angel Burguillos et al. Cell Reports
- Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
- (2015) Alan Kirwan et al. Biomed Research International
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Heat-Modified Citrus Pectin Induces Apoptosis-Like Cell Death and Autophagy in HepG2 and A549 Cancer Cells
- (2015) Lionel Leclere et al. PLoS One
- Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
- (2015) Thapi D. Rao et al. PLoS One
- Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex
- (2014) Ming-Heng Wu et al. ANGIOGENESIS
- Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics
- (2014) Helen Blanchard et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists
- (2014) Vishal Kumar Rajput et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Abstract 33: OTX008 pharmacokinetics (PK) during the first-in-man phase I study in patients with advanced solid tumors .
- (2014) Keyvan Rezai et al. CANCER RESEARCH
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands
- (2014) Samy Cecioni et al. CHEMICAL REVIEWS
- Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response
- (2014) P. Kuo et al. CLINICAL CANCER RESEARCH
- OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
- (2014) Lucile Astorgues-Xerri et al. EUROPEAN JOURNAL OF CANCER
- Induction of galectin-1 by TGF-β1 accelerates fibrosis through enhancing nuclear retention of Smad2
- (2014) Min Jin Lim et al. EXPERIMENTAL CELL RESEARCH
- Structural basis of redox-dependent modulation of galectin-1 dynamics and function
- (2014) Carlos M Guardia et al. GLYCOBIOLOGY
- Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer
- (2014) Leonardo Mirandola et al. GYNECOLOGIC ONCOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Design and Synthesis of Hydrolytically Stable Multivalent Ligands Bearing Thiodigalactoside Analogues for Peanut Lectin and Human Galectin-3 Binding
- (2014) Alejandro J. Cagnoni et al. JOURNAL OF ORGANIC CHEMISTRY
- The Role and Importance of Glycosylation of Acute Phase Proteins with Focus on Alpha-1 Antitrypsin in Acute and Chronic Inflammatory Conditions
- (2014) Cormac McCarthy et al. JOURNAL OF PROTEOME RESEARCH
- Targeting Prostate Carcinoma by G3-C12 Peptide Conjugated N-(2-Hydroxypropyl)methacrylamide Copolymers
- (2014) Yang Yang et al. MOLECULAR PHARMACEUTICS
- Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors
- (2014) V Veschi et al. Cell Death & Disease
- Aberrant Glycosylation Promotes Lung Cancer Metastasis through Adhesion to Galectins in the Metastatic Niche
- (2014) Nathan E. Reticker-Flynn et al. Cancer Discovery
- An In Vivo Functional Screen Identifies ST6GalNAc2 Sialyltransferase as a Breast Cancer Metastasis Suppressor
- (2014) N. Murugaesu et al. Cancer Discovery
- Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis
- (2014) Diego O Croci et al. OncoImmunology
- Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis
- (2013) Roy Heusschen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Design and synthesis of glycoprotein-based multivalent glyco-ligands for influenza hemagglutinin and human galectin-3
- (2013) Helen Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
- (2013) Massimo Zucchetti et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Increased Circulation of Galectin-3 in Cancer Induces Secretion of Metastasis-Promoting Cytokines from Blood Vascular Endothelium
- (2013) C. Chen et al. CLINICAL CANCER RESEARCH
- Vascular galectins: Regulators of tumor progression and targets for cancer therapy
- (2013) Victor L. Thijssen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
- (2013) A. C. MacKinnon et al. GLYCOBIOLOGY
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer
- (2013) Ruud P. M. Dings et al. INVESTIGATIONAL NEW DRUGS
- Tuning the Preference of Thiodigalactoside- and Lactosamine-Based Ligands to Galectin-3 over Galectin-1
- (2013) Hilde van Hattum et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Possible Role of Galectin-9 in the Pulmonary Fibrosis of Patients with Interstitial Pneumonia
- (2013) Nobuhiro Matsumoto et al. LUNG
- Density-dependent Lectin–Glycan Interactions as a Paradigm for Conditional Regulation by Posttranslational Modifications
- (2013) James W. Dennis et al. MOLECULAR & CELLULAR PROTEOMICS
- Galectin-3 Accelerates the Progression of Oral Tongue Squamous Cell Carcinoma via a Wnt/β-catenin-Dependent Pathway
- (2013) Li-Ping Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis
- (2013) P. Guha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-1 Controls Cardiac Inflammation and Ventricular Remodeling during Acute Myocardial Infarction
- (2012) Ignacio M. Seropian et al. AMERICAN JOURNAL OF PATHOLOGY
- Peptide–Drug Conjugate Linked via a Disulfide Bond for Kidney Targeted Drug Delivery
- (2012) Qian Geng et al. BIOCONJUGATE CHEMISTRY
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
- (2012) D. J. Laderach et al. CANCER RESEARCH
- Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss
- (2012) R. E. Ramhorst et al. GLYCOBIOLOGY
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
- (2012) Sarah C. Starossom et al. IMMUNITY
- Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells
- (2012) Cécile Boscher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway
- (2012) Keng-Liang Wu et al. JOURNAL OF GASTROENTEROLOGY
- Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression
- (2012) F. Cedeno-Laurent et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 Regulates Intracellular Trafficking of EGFR through Alix and Promotes Keratinocyte Migration
- (2012) Wei Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
- (2012) Ruud P. M. Dings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
- (2011) Santiago Di Lella et al. BIOCHEMISTRY
- Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates
- (2011) Yang Yang et al. BIOMATERIALS
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
- (2011) J. Ouyang et al. BLOOD
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- Arene-Anion Based Arginine-Binding Motif on a Galactose Scaffold: Structure-Activity Relationships of Interactions with Arginine-Rich Galectins
- (2011) Christopher T. Öberg et al. CHEMISTRY-A EUROPEAN JOURNAL
- Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor
- (2011) Geoffrey Masuyer et al. FEBS Journal
- Structural features for α-galactomannan binding to galectin-1
- (2011) Michelle C Miller et al. GLYCOBIOLOGY
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins
- (2011) Emma Salomonsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer
- (2011) Eva Kopansky et al. JOURNAL OF DRUG TARGETING
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
- (2011) Leonardo Mirandola et al. PLoS One
- Galectins: regulators of acute and chronic inflammation
- (2010) Fu-Tong Liu et al. Annals of the New York Academy of Sciences
- 1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
- (2010) Bader A. Salameh et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Multimeric Lactoside “Click Clusters” as Tools to Investigate the Effect of Linker Length in Specific Interactions with Peanut Lectin, Galectin-1, and -3
- (2010) Sébastien G. Gouin et al. CHEMBIOCHEM
- PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and- Independent Prostate Cancer Cells
- (2010) Jun Yan et al. INTEGRATIVE CANCER THERAPIES
- Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
- (2010) Pratima Nangia-Makker et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
- (2010) Carla Iacobini et al. JOURNAL OF HEPATOLOGY
- Allergen-Induced Airway Remodeling Is Impaired in Galectin-3-Deficient Mice
- (2010) X. N. Ge et al. JOURNAL OF IMMUNOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of citrus pectin on malignant cell proliferation
- (2009) M. Bergman et al. BIOMEDICINE & PHARMACOTHERAPY
- The -galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
- (2009) M. C Miller et al. GLYCOBIOLOGY
- The regulation of inflammation by galectin-3
- (2009) Neil C. Henderson et al. IMMUNOLOGICAL REVIEWS
- Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size
- (2009) S. D. Liu et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
- (2009) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Roles of galectins in infection
- (2009) Gerardo R. Vasta NATURE REVIEWS MICROBIOLOGY
- Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3
- (2009) Johan Tejler et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
- (2009) H.-Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
- (2008) Vladislav V. Glinsky et al. CARBOHYDRATE RESEARCH
- Calix[n]arene‐Based Glycoclusters: Bioactivity of Thiourea‐Linked Galactose/Lactose Moieties as Inhibitors of Binding of Medically Relevant Lectins to a Glycoprotein and Cell‐Surface Glycoconjugates and Selectivity among Human Adhesion/Growth‐Regulatory Galectins
- (2008) Sabine André et al. CHEMBIOCHEM
- Double Affinity Amplification of Galectin–Ligand Interactions through Arginine–Arene Interactions: Synthetic, Thermodynamic, and Computational Studies with Aromatic Diamido Thiodigalactosides
- (2008) Ian Cumpstey et al. CHEMISTRY-A EUROPEAN JOURNAL
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Ligand Reduces Galectin-1 Sensitivity to Oxidative Inactivation by Enhancing Dimer Formation
- (2008) Sean R. Stowell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group Antigens
- (2008) Sean R. Stowell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arginine Binding Motifs: Design and Synthesis of Galactose-Derived Arginine Tweezers as Galectin-3 Inhibitors
- (2008) Christopher T. Öberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
- (2008) Tamara Delaine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-1 Is a Novel Structural Component and a Major Regulator of H-Ras Nanoclusters
- (2008) Liron Belanis et al. MOLECULAR BIOLOGY OF THE CELL
- Protein-glycan interactions in the control of innate and adaptive immune responses
- (2008) Yvette van Kooyk et al. NATURE IMMUNOLOGY
- Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
- (2008) S H Hsieh et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started